FLT3 and acute myeloid leukemia: It is the most common mutation found in AML patients, up to 30%, acquired by internal tandem duplications (FLT3-ITD) of the cytoplasmic domain of FLT3 (14, 16–20) and causes ligand independent signaling (16, 21).